Żelazny P, Filipczak J, Sygacz O, Bróż S, Dankiewicz S, Swora A, et al. Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF). J Educ Health Sport [Internet]. 2022 Sep. 8 [cited 2025 Mar. 25];12(9):583-8. Available from: https://apcz.umk.pl/JEHS/article/view/39770